Skip to main content
. 2020 Oct 1;15(2):360–368. doi: 10.1055/s-0040-1715914

Table 2. Quality assessment of the included studies.

Author H S A/G IC EC T MO SS SSJ CG RA MRA B E ECL SM FR FR80% LF M AN CI AE C %*
Abbreviations: A/G, age/gender distribution described; AE, adverse events stated; AN, results stated in absolute numbers; B, blinding performed; C, conclusions stated; CG, use of control group; CI, confidence intervals stated; E, more than one examiner for outcome assessment; EC, exclusion criteria; ECL, examiner calibration; FR, follow-up rate mentioned; FR80%, follow-up rate greater than 80%; H, hypothesis/aim described; IC, inclusion criteria; LF, lost to follow-up; M, main outcomes clearly described; MO, main outcomes to be measured; MRA, method of random allocation described; RA, random allocation to treatment used; S, study setting described; SM, statistical methods described; SS, sample size; SSJ, sample size justified; T, treatment described; x, yes.
*% of questions answered yes.
Olley et al (2018) 38 x x x x x x x x x x x x x x x x x x x 79
Layton & Walton (2012) 36 x x x x x x x x x x x x x x x x x x x x x 87
Beier et al (2012) 39 x x x x x x x x x x x x x x x x x x x x x 87
Layton & Walton (2007) 35 x x x x x x x x x x x x x x x 62
Friedman (1998) 34 x x x x x x x x x x x x x x 58
Gurel et al (2013) 29 x x x x x x x x x x x x x x x x x x x 79
Fradeani et al (2005) 4 x x x x x x x x x x x x x x x x x x 75
Granell-Ruiz et al (2009) 30 x x x x x x x x x x x x x x x x x x x x x x 92
Dumfahrt & Schäffer (2000) 31 x x x x x x x x x x x x x x x 67
Burke & Lucarotti (2009) 32 x x x x x x x x x x x x x x x x x x 75
Peumans et al (2004) 33 x x x x x x x x x x x x x x x x x x x 79
D’Arcangelo et al (2012) 18 x x x x x x x x x x x x x x x x x x x x x x 92
Shao-Ping et al (2012) 19 x x x x x x x x x x x x x x x x x x 75
Smales & Etemadi (2004) 20 x x x x x x x x x x x x x x x x x 71
Magne et al (2000) 21 x x x x x x x x x x x x x x x x x x 75
Shaini et al (1997) 22 x x x x x x x x x x x x x x x x x 77
Fradeani (1998) 23 x x x x x x x x x x x x x x x 62
Aykor & Ozel (2009) 24 x x x x x x x x x x x x x x x x x x x 79
Guess & Stappert (2008) 25 x x x x x x x x x x x x x x x x x x x x 83
Murphy et al (2005) 26 x x x x x x x x x x x x x x x x x x 75
Aristidis & Dimitra (2002) 27 x x x x x x x x x x x x x x x x x x x x x 87
Peumans et al (1998) 28 x x x x x x x x x x x x x x x 62
Coelho-de-Souza et al (2015) 10 x x x x x x x x x x x x x x x x x x x 79
Fabbri et al (2014) 11 x x x x x x x x x x x x x x x x x x 75
Gresnigt et al (2013) 12 x x x x x x x x x x x x x x x x x x x 79
Rinke et al (2013) 13 x x x x x x x x x x x x x x x x x x x x x 87
Nordbø et al (1994) 14 x x x x x x x x x x x x x x x x x x 75
Karagözoğlu et. al. (2016) 15 x x x x x x x x x x x x x x x x x x x x x x x 96
Öztürk & Bolay (2014) 16 x x x x x x x x x x x x x x x x x x x x x x 83
Çötert et al (2009) 17 x x x x x x x x x x x x x x x x x x x x x 87